GGrantIndex
Sort

21,453 grants matching tuberculosis

A clinical decision tool to optimize the selection of antibiotics for patients with rifampicin-resistant Tuberculosis

$700,666
Reza Yaesoubi · Yale University · R01 · FY2025 · AI

IgM in the regulation of TB immunity

$700,549
John R. Chan · Albert Einstein College Of Medicine · R01 · FY2019 · AI

Intracellular Pathogens and Innate Immunity

$700,494
University Of California Berkeley · P01 · FY2004 · AI

Development of Novel mRNA Vaccines Against Mycobacterium tuberculosis

$700,469
Thomas Siegmund Postler · International Aids Vaccine Initiative · R33 · FY2025 · AI

GH21-001, Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health (MOPH) in the Kingdom of Thailand

$700,140
Opart Karnkawinpong · Thailand Ministry Of Public Health · U01 · FY2023 · GH

Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting

$700,111
James C M Brust · Albert Einstein College Of Medicine · R01 · FY2022 · AI

A novel cartridge-based sequencing solution for decentralized M. tuberculosis resistance detection

$700,104
John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2025 · AI

Single-cell factors of tuberculosis drug tolerance during adaptation to environmental stressors

$700,050
Bree Beardsley Aldridge · Tufts University Boston · R01 · FY2020 · AI

SOC Core

$700,028
Aleksandar Milosavljevic · Baylor College Of Medicine · U54 · FY2015 · DA

SOC Core

$700,028
Aleksandar Milosavljevic · Baylor College Of Medicine · U54 · FY2016 · DA

A robust platform for multiplexed, subcellular proteomic imaging in human tissue

$700,000
Robert Michael Angelo · Stanford University · UH3 · FY2020 · CA

9th IAS Conference on HIV Science (IAS 2017), Paris, France, 23-26 July 2017

$700,000
Chris Beyrer · Ias · R13 · FY2017 · AI

SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial

$699,889
Adithya Cattamanchi · University Of California, San Francisco · R01 · FY2016 · HL

Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission

$699,820
Edward A. Nardell · Brigham And Women'S Hospital · R01 · FY2018 · AI

IL-2/Treg-based immunity to TB and AIDS-related TB

$699,743
Zheng W Chen · University Of Illinois At Chicago · R01 · FY2012 · HL

Development of sustained release/long acting products for TB

$699,668
J. Victor Garcia-Martinez · University Of Alabama At Birmingham · R56 · FY2023 · AI

Minimizing in vivo Drug Tolerance induction in tuberculosis.

$699,638
David G Russell · Rutgers Biomedical And Health Sciences · U19 · FY2023 · AI

Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting

$699,465
James C M Brust · Albert Einstein College Of Medicine · R01 · FY2021 · AI

Sepsis Characterization in Kilimanjaro

$699,273
Matthew P Rubach · Duke University · R01 · FY2020 · AI

Understanding and Improving the Effectiveness of Public Health Laboratory Networks for Infectious Diseases in Ghana

$698,829
Lee Frederick Schroeder · University Of Michigan At Ann Arbor · R01 · FY2019 · AI

Genetics & Clinical Cohorts

$698,804
Sarah Jane Dunstan · University Of Washington · U19 · FY2021 · AI

Optimization of Atypical Antimycobacterial Carbapenem Antibiotics

$698,616
John D Buynak · Southern Methodist University · R01 · FY2024 · AI

Animal Model Core

$698,474
David S Perlin · Rbhs-New Jersey Medical School · U19 · FY2014 · AI

Metabolomics Core

$698,471
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2015 · AI

Animal Model Core

$698,460
David S Perlin · Rbhs-New Jersey Medical School · U19 · FY2017 · AI